Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Estrogen Receptor/ERR
    (2)
  • Estrogen/progestogen Receptor
    (1)
  • Others
    (4)
Filter
Search Result
Results for "

a-hydroxytamoxifen

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    7
    TargetMol | Activity
  • PROTAC Products
    1
    TargetMol | inventory
  • Natural Products
    1
    TargetMol | natural
Droloxifene
3-Hydroxytamoxifen
T1109882413-20-5In house
Droloxifene (3-Hydroxytamoxifen), a tamoxifen derivative, is an oral active and selective estrogen receptor modulator.Droloxifene induced p53 expression and apoptosis in McF-7 cells.Fluroxifene has anti-estrogen and anti-implantation effects.Fluroxifene prevented bone loss in ovariectomized rats.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Sale
(E/Z)-4-Hydroxytamoxifen
Afimoxifene,4-Hydroxytamoxifen
T674368392-35-8
(E Z)-4-Hydroxytamoxifen (Afimoxifene) is a novel estrogen inhibitor, commonly used in research for various estrogen-dependent conditions, including cyclic mastalgia and gynecomastia.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
(E)-4-Hydroxytamoxifen
T15186174592-47-3
(E)-4-Hydroxytamoxifen is a less active isomer of (Z)-4-hydroxytamoxifen and also is an estrogen receptor modulator.
  • Inquiry Price
7-10 days
Size
QTY
SNIPER(ER)-87
T186972222354-91-6
SNIPER(ER)-87 is a chemical compound composed of a derivative of the inhibitor of apoptosis protein (IAP) ligand LCL161 conjugated to the estrogen receptor α (ERα) ligand 4-hydroxytamoxifen using a PEG linker. It effectively degrades the ERα protein with an IC50 value of 0.097 μM. Within cells, SNIPER(ER)-87 selectively recruits XIAP to ERα, and XIAP functions as the primary E3 ubiquitin ligase responsible for the degradation of ERα induced by SNIPER(ER)-87[1][2].
  • Inquiry Price
Size
QTY
Endoxifen mesylate
T715781032008-71-1
Endoxifen, also known as N-desmethyl-4-hydroxytamoxifen, is a chemical that is under development for estrogen receptor-positive breast cancer. It is also being evaluated as an antipsychotic for treatment of mania and other psychotic disorders. Endoxifen is a nonsteroidal selective estrogen receptor modulator (SERM) of the triphenylethylene group. It is an active metabolite of tamoxifen and has been found to be effective in patients that have failed previous hormonal therapies (tamoxifen, aromatase inhibitors, and fulvestrant). The prodrug tamoxifen is metabolized by the CYP2D6 enzyme to produce afimoxifene (4-hydroxytamoxifen) and endoxifen.
  • Inquiry Price
6-8 weeks
Size
QTY
Isoerysenegalensein E
TN5456478158-77-9
Isoerysenegalensein E shows anti-estrogenic activity comparable to that of 4-hydroxytamoxifen, a typical estrogen receptor antagonist. It shows significant cytotoxicity against HL-60 cells, it induces apoptosis in HL-60 cells through activation of the cas
  • Inquiry Price
Size
QTY
α-Hydroxytamoxifen
α-OHTAM,(E)-α-Hydroxy tamoxifen
T1919297151-02-5
α-Hydroxytamoxifen, a metabolite of tamoxifen, reacts with DNA and forms DNA adducts.
  • Inquiry Price
Size
QTY